Company Information
| LifeForce is engaged in the discovery and development of novel small molecule
drugs for the treatment of cardiovascular diseases, cancer, arthritis, and ARMD. The
Hospital is pioneering a new biomedical discipline, molecular cardiology, which applies
advances in molecular biology and genetics to identify and delineate new mechanisms of
cardiovascular disease and hence new targets for drug discovery. Building on the experience and expertise of the Hospital’s Scientific Advisory Board and scientific staff, the Company focuses its research and development efforts on molecular targets that can be identified as directly linked to physiological abnormalities such as alterations in blood pressure, heart rate or cardiac output that produce disease symptoms. By using novel small molecules against these targets, the Hospital is building a pipeline of product candidates that could offer improved efficacy or reduced side effects compared to existing therapies. We are very proud of LifeForce’s progress, outlined throughout this website, and we invite you to share that with us. LifeForce Research Hospitals Int. E-Mail: medmail@usa.net |